Since mid-2020, Canadian insurers and banks have been issuing deeply subordinated capital instruments targeted to institutional investors, that are known as Limited Recourse Capital Notes and Non-Viability Contingent Capital Additional Tier 1 (AT1) Limited Recourse Capital Notes respectively (together, LRCNs). Recent global market developments, including the banking failures in the U.S. and the wipe out of Credit Suisse’s AT1 notes, have adversely affected the market for new issuances.
In this Frontline Perspectives webinar, Nadja Dreff, Senior Vice President, Head of Canadian Insurance will be joined by Kris Somers, Managing Director, BMO Capital Markets. The conversation will review and discuss the recent LRCN market developments and provide an outlook for the future of LRCN issuances in Canada.